View in EDS HTML Full Text PDF Full Text

COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network.

Saved in:
Bibliographic Details
Title: COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network.
Authors: Laniece Delaunay C; Epiconcept, Paris, France., Verdasca N; Infectious Disease Department, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal., Monge S; National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain., Domegan L; Health Service Executive, Health Protection Surveillance Centre, Dublin, Ireland., Sève N; Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP), Paris, France., Buda S; Department of Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany., Meijer A; National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Bilthoven, the Netherlands., Lucaccioni H; Epiconcept, Paris, France., López Torrijos M; Subdirección General de Epidemiología y Vigilancia de la Salud, Valencia, Spain., McKenna A; Health Service Executive, Health Protection Surveillance Centre, Dublin, Ireland., Enouf V; Centre National de Référence Virus des Infections Respiratoire (CNR VIR), M3P Unit, Institut Pasteur Université Paris Cité, Paris, France., Dürrwald R; National Reference Centre for Influenza, Robert Koch Institute, Berlin, Germany., In't Velt E; National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Bilthoven, the Netherlands., de Valcárcel Laiglesia MÁ; Department of Epidemiology, Regional Health Council, IMIB, Murcia, Spain., Bennett C; National Virus Reference Laboratory, University College, Dublin, Ireland., Masse S; Unite des Virus Emergents (UVE: Aix-Marseille Univ, Universita di Corsica, IRD 190, Inserm 1207, IRBA), Marseille, France., Erdwiens A; Department of Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany., Hooiveld M; Nivel, Utrecht, the Netherlands., Mlinarić I; Croatian Institute of Public Health, Zagreb, Croatia., Túri G; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Rodrigues AP; Epidemiology Department, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal., Martínez-Baz I; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain., Lazar M; Cantacuzino National Military Medical Institute for Research and Development, Bucharest, Romania., Latorre-Margalef N; Department of Microbiology, Public Health Agency of Sweden, Stockholm, Sweden., Borges V; Infectious Disease Department, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal., Kaczmarek M; European Centre for Disease Control and Prevention, Stockholm, Sweden., Bacci S; European Centre for Disease Control and Prevention, Stockholm, Sweden., Kissling E; Epiconcept, Paris, France.
Corporate Authors: European primary care VE group
Source: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2025 May; Vol. 19 (5), pp. e70120.
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print Cited Medium: Internet ISSN: 1750-2659 (Electronic) Linking ISSN: 17502640 NLM ISO Abbreviation: Influenza Other Respir Viruses Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40395132
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Laniece+Delaunay+C%22">Laniece Delaunay C</searchLink>; Epiconcept, Paris, France.<br /><searchLink fieldCode="AU" term="%22Verdasca+N%22">Verdasca N</searchLink>; Infectious Disease Department, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Monge+S%22">Monge S</searchLink>; National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Domegan+L%22">Domegan L</searchLink>; Health Service Executive, Health Protection Surveillance Centre, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Sève+N%22">Sève N</searchLink>; Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Buda+S%22">Buda S</searchLink>; Department of Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Meijer+A%22">Meijer A</searchLink>; National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Bilthoven, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Lucaccioni+H%22">Lucaccioni H</searchLink>; Epiconcept, Paris, France.<br /><searchLink fieldCode="AU" term="%22López+Torrijos+M%22">López Torrijos M</searchLink>; Subdirección General de Epidemiología y Vigilancia de la Salud, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22McKenna+A%22">McKenna A</searchLink>; Health Service Executive, Health Protection Surveillance Centre, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Enouf+V%22">Enouf V</searchLink>; Centre National de Référence Virus des Infections Respiratoire (CNR VIR), M3P Unit, Institut Pasteur Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Dürrwald+R%22">Dürrwald R</searchLink>; National Reference Centre for Influenza, Robert Koch Institute, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22In't+Velt+E%22">In't Velt E</searchLink>; National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Bilthoven, the Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Valcárcel+Laiglesia+MÁ%22">de Valcárcel Laiglesia MÁ</searchLink>; Department of Epidemiology, Regional Health Council, IMIB, Murcia, Spain.<br /><searchLink fieldCode="AU" term="%22Bennett+C%22">Bennett C</searchLink>; National Virus Reference Laboratory, University College, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Masse+S%22">Masse S</searchLink>; Unite des Virus Emergents (UVE: Aix-Marseille Univ, Universita di Corsica, IRD 190, Inserm 1207, IRBA), Marseille, France.<br /><searchLink fieldCode="AU" term="%22Erdwiens+A%22">Erdwiens A</searchLink>; Department of Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Hooiveld+M%22">Hooiveld M</searchLink>; Nivel, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Mlinarić+I%22">Mlinarić I</searchLink>; Croatian Institute of Public Health, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Túri+G%22">Túri G</searchLink>; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Rodrigues+AP%22">Rodrigues AP</searchLink>; Epidemiology Department, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Martínez-Baz+I%22">Martínez-Baz I</searchLink>; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Lazar+M%22">Lazar M</searchLink>; Cantacuzino National Military Medical Institute for Research and Development, Bucharest, Romania.<br /><searchLink fieldCode="AU" term="%22Latorre-Margalef+N%22">Latorre-Margalef N</searchLink>; Department of Microbiology, Public Health Agency of Sweden, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Borges+V%22">Borges V</searchLink>; Infectious Disease Department, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Kaczmarek+M%22">Kaczmarek M</searchLink>; European Centre for Disease Control and Prevention, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Bacci+S%22">Bacci S</searchLink>; European Centre for Disease Control and Prevention, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Kissling+E%22">Kissling E</searchLink>; Epiconcept, Paris, France.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22European+primary+care+VE+group%22">European primary care VE group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101304007%22">Influenza and other respiratory viruses</searchLink> [Influenza Other Respir Viruses] 2025 May; Vol. 19 (5), pp. e70120.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101304007 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1750-2659 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217502640%22">17502640 </searchLink><i>NLM ISO Abbreviation: </i>Influenza Other Respir Viruses <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40395132
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/irv.70120
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70120
    Titles:
      – TitleFull: COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Laniece Delaunay C
      – PersonEntity:
          Name:
            NameFull: Verdasca N
      – PersonEntity:
          Name:
            NameFull: Monge S
      – PersonEntity:
          Name:
            NameFull: Domegan L
      – PersonEntity:
          Name:
            NameFull: Sève N
      – PersonEntity:
          Name:
            NameFull: Buda S
      – PersonEntity:
          Name:
            NameFull: Meijer A
      – PersonEntity:
          Name:
            NameFull: Lucaccioni H
      – PersonEntity:
          Name:
            NameFull: López Torrijos M
      – PersonEntity:
          Name:
            NameFull: McKenna A
      – PersonEntity:
          Name:
            NameFull: Enouf V
      – PersonEntity:
          Name:
            NameFull: Dürrwald R
      – PersonEntity:
          Name:
            NameFull: In't Velt E
      – PersonEntity:
          Name:
            NameFull: de Valcárcel Laiglesia MÁ
      – PersonEntity:
          Name:
            NameFull: Bennett C
      – PersonEntity:
          Name:
            NameFull: Masse S
      – PersonEntity:
          Name:
            NameFull: Erdwiens A
      – PersonEntity:
          Name:
            NameFull: Hooiveld M
      – PersonEntity:
          Name:
            NameFull: Mlinarić I
      – PersonEntity:
          Name:
            NameFull: Túri G
      – PersonEntity:
          Name:
            NameFull: Rodrigues AP
      – PersonEntity:
          Name:
            NameFull: Martínez-Baz I
      – PersonEntity:
          Name:
            NameFull: Lazar M
      – PersonEntity:
          Name:
            NameFull: Latorre-Margalef N
      – PersonEntity:
          Name:
            NameFull: Borges V
      – PersonEntity:
          Name:
            NameFull: Kaczmarek M
      – PersonEntity:
          Name:
            NameFull: Bacci S
      – PersonEntity:
          Name:
            NameFull: Kissling E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2025 May
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1750-2659
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Influenza and other respiratory viruses
              Type: main
ResultId 1